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ABSTRACT The interaction of cardiotoxin Ila, a small basic protein extracted from Naja mossambica mossambica venom,
with dimyristoylphosphatidic acid (DMPA) membranes has been investigated by solid-state 31P nuclear magnetic resonance
spectroscopy. Both the spectral lineshapes and transverse relaxation time values have been measured as a function of
temperature for different lipid-to-protein molar ratios. The results indicate that the interaction of cardiotoxin with DMPA gives
rise to the complete disappearance of the bilayer structure at a lipid-to-protein molar ratio of 5:1. However, a coexistence of
the lamellar and isotropic phases is observed at higher lipid contents. In addition, the number of phospholipids interacting
with cardiotoxin increases from about 5 at room temperature to approximately 15 at temperatures above the phase transition
of the pure lipid. The isotropic structure appears to be a hydrophobic complex similar to an inverted micellar phase that can
be extracted by a hydrophobic solvent. At a lipid-to-protein molar ratio of 40:1, the isotropic structure disappears at high
temperature to give rise to a second anisotropic phase, which is most likely associated with the incorporation of the
hydrophobic complex inside the bilayer.
INTRODUCTION
Cardiotoxins are basic proteins extracted from snake
venom. They have a molecular weight of about 7000 and are
highly stabilized by the presence of four disulfide bridges
(Louw, 1974). Even though cardiotoxins display a lower
toxicity than neurotoxins, they generally represent the major
content of snake venom. The structures of several cardio-
toxins have been investigated by circular dichroism (Louw
and Visser, 1978; M6nez et al., 1978), Raman spectroscopy
(Pezolet et al., 1982), and Fourier transform infrared (FTIR)
spectroscopy (Surewicz et al., 1988; Desormeaux et al.,
1992), and the complete structures of at least two cardio-
toxins of Naja mossambica mossambica have been deter-
mined by x-ray crystallography (Rees et al., 1987) and
nuclear magnetic resonance (NMR) spectroscopy (Stein-
metz et al., 1988; O'Connell et al., 1993).
The mechanism of action of cardiotoxins on cell mem-
branes is still a matter of controversy, but there is a general
agreement that cardiotoxins act by perturbing the lipid
phase of cell membranes (Bougis et al., 1981, 1983; Menez
et al., 1990). On the basis of the large amount of cardio-
toxins that were observed to be bound to biological mem-
branes, it has been proposed that lipids were involved in this
binding (Vincent et al., 1976). Fluorescence studies have
established that cardiotoxins interact only with negatively
charged phospholipids at a lipid-to-protein molar ratio of
7:1 (Dufourcq and Faucon, 1978; Vincent et al., 1978) for
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singly charged phospholipids and at a molar ratio of 3.5 for
doubly charged phospholipids (Dufourcq and Faucon, 1978;
Faucon et al., 1983; Batenburg et al., 1985).
Several studies have been performed to elucidate the
mechanism of action of cardiotoxins on cell membranes.
Many observations suggest considerable changes of the
lipid organization upon binding of cardiotoxins. Such phe-
nomena include the liberation of intramembrane proteins
investigated by freeze-fracture electron microscopy (Gulik-
Krzywicki et al., 1981), the liberation of trapped fluorescent
species (Faucon et al., 1979), and the abolition of the
thermotropic phase transition of dimyristoylphosphatidic
acid (DMPA) bilayers observed by differential scanning
calorimetry (DSC), fluorescence polarization, Raman spec-
troscopy (Faucon et al., 1981, 1983), and FTIR spectros-
copy (Desormeaux et al., 1992). Furthermore, the synergetic
action of cardiotoxin and phospholipase A2 is a well-known
phenomenon (Louw and Visser, 1978; Gulik-Krzywicki et
al., 1981; Rivas et al., 1981; Harvey et al., 1983) that can be
easily explained by a perturbation of the lipid bilayer. On
the other hand, a study by attenuated total reflection FTIR
spectroscopy and x-ray crystallography has shown that the
complex between DMPA and cardiotoxin is poorly ordered
(D6sormeaux et al., 1992).
To explain these data, three models of interaction have
been suggested. Two models proposed a bilayer structure
with a partial incorporation of cardiotoxin in the hydropho-
bic region of the bilayer (Lauterwein and Wiithrich, 1978;
Dufourcq et al., 1982). A third model proposed a double
inverted micellar structure with a disappearance of the bi-
layer structure (Batenburg et al., 1985).
Solid-state 31p NMR spectroscopy is a valuable tech-
nique for studying the different phases formed by model
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phospholipid membranes. The 31P NMR lineshapes are very
characteristic of the different phases, such as the gel and
liquid-crystalline lamellar phases, the inverted hexagonal
phase, and isotropic phases such as small vesicles and
micelles (Seelig, 1978; Smith and Ekiel, 1984; Lindblom
and Rilfors, 1989; Seddon, 1990a). On the other hand, the
dynamics of the lipid headgroup can be studied by 31pNMR
longitudinal relaxation time (T1) (Milburn and Jeffrey,
1987, 1989, 1990) and 31P NMR transversal relaxation time
(T2) (Dufourc et al., 1992).
In the present study we have investigated the interaction
between the cardiotoxin Ha of Naja mossambica mossam-
bica with dimyristoylphosphatidic acid at different lipid-to-
protein molar ratios by 31p solid-state NMR. The results
indicate that the interaction of cardiotoxin with DMPA
results in a complete disappearance of the bilayer structure
at a lipid-to-protein molar ratio of 5:1 and in a partial
disappearance at higher molar ratios (15:1 and 40:1). The
isotropic structure appears to be a hydrophobic complex
similar to an inverted micellar phase that gives rise to an
isotropic peak in the 31P NMR spectra. At a lipid-to-protein
molar ratio of 40: 1, a second anisotropic lineshape is present
at high temperatures that is most likely associated with the
incorporation of the hydrophobic complex inside the bi-
layer.
MATERIALS AND METHODS
Materials
The disodium salt of dimyristoylphosphatidic acid (DMPA) was obtained
from Avanti Polar Lipids (Alabaster, AL) and used without further puri-
fication. Cardiotoxin Ha (hereafter called cardiotoxin) was purified from
Naja mossambica mossambica venom according to the method described
by Bougis et al. (1986). The concentration of cardiotoxin was determined
from the absorbance at 280 nm.
Sample preparation
The sample preparation was based on the method of Desormeaux et al.
(1992). Solutions of cardiotoxin at a concentration of 2% were prepared in
150 mM NaCl and 10 mM EDTA. The pH of the solutions was measured
with a microelectrode (Microelectrodes, Inc., Londonderry, NH) and ad-
justed to 6.5 with diluted NaOH or HCI solutions. Aqueous dispersions of
DMPA were prepared by mixing appropriate amounts of solid in 150 mM
NaCl and 10 mM EDTA, adjusted to pH 6.5 with diluted NaOH or HCI
solutions. Samples containing about 10% by weight in lipids were then
heated to approximately 65°C for 10 min, stirred on a vortex mixer, and
cooled down at 0°C for 10 min. This cycle was repeated at least five times
the day before the analysis and five times the day of the analysis. The pH
of the dispersions was adjusted to 6.5, if necessary. Lipid-protein com-
plexes were prepared by adding the appropriate amount of 2% cardiotoxin
solution to phospholipid dispersions to obtain the desired lipid-to-protein
molar ratio. The addition was made after the first five temperature cycles.
The samples were then centrifuged to yield white pellets that were used in
the NMR experiments. All of the samples were analyzed within 4 days of
their preparation.
Hydrophobic extraction
The hydrophobic extraction was performed according to the method of
Batenburg et al. (1985). A total of 20 nmol of cardiotoxin in 100 ,ul of
aqueous solution (150 mM NaCl and 10 mM EDTA) was added to 430 jLI
of chloroform/methanol, 5:8 (v/v), containing 900 nmol of DMPA. The
phase separation was induced by the addition of 370 ,ul chloroform and 100
,ul aqueous solution (150 mM NaCl and 10 mM EDTA), followed by a 10
min of centrifugation at 14,000 rpm. The aqueous phase was then analyzed
by spectrophotometry at 280 nm.
NMR experiments
All of the 31p spectra were acquired at 121.5 MHz on a Bruker ASX-300
(Bruker Spectrospin, Milton, ON) operating at a 'H frequency of 300.00
MHz. Experiments were carried out with a broadband/1H dual-frequency
4-mm probehead under conditions of proton decoupling. The free induction
decays (2 K data points) were recorded with a spin echo sequence (4000
scans) with a 5-s repetition time. The temperature was controlled to within
±0.5°C and the chemical shifts (expressed in ppm) were referenced
relative to the signal of phosphoric acid at 0 ppm. The transverse relaxation
times were measured with a spin echo sequence using 20 interpulse delays
(T) varying between 10 ,us and 4 ms. Five hundred twelve scans were used
for the relaxation time experiments. A line broadening of 300 Hz was
applied to all spectra. The T2 values were calculated from the decay of
intensity as a function of 2T, using either a mono- or biexponential decay.
The integrated areas of the whole spectra have been used in the calcula-
tions, and therefore the exponential decays reflect the relaxation behavior
of the different phases present in the spectra.
Spectral simulations
The powder spectra obtained for the DMPA-cardiotoxin complexes have
been simulated by using different proportions of one or two powder spectra
with different chemical shift anisotropies and an isotropic peak. The
isotropic peak was always centered at 0 ppm and its width (denoted in
Table 1 as width at half-height (WHH)) was varied between 4 ppm and 11
ppm to fit the experimental spectra. Line broadening was used in the
simulations of the anisotropic spectra to fit the experimental spectra. The
quality of the fit was determined by visual comparison of the experimental
and simulated spectra. We estimate that the error on the calculated pro-
portions of each phase is on the order of 3%.
RESULTS
Spectral lineshapes
The 31P NMR spectra of pure DMPA bilayers as a function
of temperature are shown in Fig. 1. In the temperature range
between 25 and 65°C, all of the spectra are axially sym-
metric and characteristic of lamellar phases (Seelig, 1978).
The spectral width decreases gradually with increasing tem-
perature, with a major change between 40 and 50°C, which
corresponds to the gel to liquid-crystalline phase transition
temperature of DMPA (48 to 50°C) (Van Dick et al., 1978;
Desormeaux et al., 1992). The smaller spectral width ob-
tained in the liquid-crystalline phase can be explained by an
additional wobbling motion of the polar headgroup (Smith
and Ekiel, 1984).
The addition of cardiotoxin to DMPA at a lipid-to-protein
molar ratio of 5:1 (Fig. 1) causes the complete disappear-
ance of the lamellar phase spectrum, and only a broad
isotropic peak is present. The width at half-height of the
isotropic peak decreases gradually from 18 ppm at 25°C to
5 ppm at 65°C. This suggests that at that lipid-to-protein
molar ratio, all of the phospholipids interact with cardio-
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FIGURE 1 Temperature dependence of the 31P NMR spectra of pure
DMPA (left) and the complex DMPA:cardiotoxin at a lipid-to-protein
molar ratio of 5:1 (right).
toxin to form an isotropic phase in which the motions are
sufficiently fast to completely average the chemical shift
anisotropy.
The addition of cardiotoxin to DMPA at a lipid-to-protein
molar ratio of 15:1 at 25°C induces the apparition of an
isotropic peak at 0 ppm superimposed on a lamellar phase
spectrum (Fig. 2). This suggests that at that temperature,
only a fraction of cardiotoxin molecules interact with the
lipids, giving rise to an isotropic peak similar to that ob-
served at a lipid-to-protein molar ratio of 5:1. With increas-
ing temperature, the intensity of the isotropic peak increases
at the expense of the lamellar phase spectrum. It is impor-
tant to note that the changes observed as a function of
temperature are fully reversible.
Spectral simulations have been performed by varying the
amounts of isotropic and lamellar spectra, and the compar-
ison with the experimental spectra obtained for a lipid-to-
protein molar ratio of 15:1 is presented in Fig. 2 as a
function of temperature. The parameters used in the simu-
lations are given in Table 1 A. These results clearly indicate
that the width at half-height of the isotropic peak decreases
and its intensity increases with increasing temperature. The
width at half-height of the isotropic peak is 11 ppm at 25°C
and 6 ppm at 65°C, and its relative intensity increases from
46% to 100% between 25 and 55°C. Above 55°C, only the
40 20 0 -20 -40 40 20 0 -20 -40
Chemical shift (ppm)
FIGURE 2 Experimental (left) and simulated (right) 31P NMR spectra as
a function of temperature for the complex DMPA:cardiotoxin at a lipid-
to-protein molar ratio of 15:1. The spectra used in the simulations are
represented by dotted lines.
isotropic peak is present, suggesting that all of the phos-
pholipids are interacting with cardiotoxin. We have calcu-
lated from the relative intensities of the two subspectra the
number of lipids in interaction with cardiotoxin as a func-
tion of temperature. This number varies from 7 at 25°C to
15 at temperatures above 55°C, indicating that there is a
change in the proportion of phospholipids that interact with
cardiotoxin as a function of temperature.
At a lipid-to-protein molar ratio of 40:1, there is still an
interaction between cardiotoxin and DMPA at room tem-
perature, as indicated by the presence of a small isotropic
peak superimposed on a nonperturbed lamellar spectrum
(Fig. 3). The isotropic peak is present at 25°C, and its
intensity increases with increasing temperature until the
phase transition to the liquid-crystalline state. At that tem-
perature, another spectrum is superimposed on the isotropic
and lamellar spectra. This new band does not exhibit a
maximum at 0 ppm, which suggests that it is due to an
anisotropic phase. In this case, spectral simulations have
been performed by varying the amounts of isotropic peak
and one or two lamellar phase spectra with different chem-
ical shift anisotropies (CSAs). The comparison between the
experimental and simulated spectra is presented in Fig. 3 as
a function of temperature, and the parameters used in the
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FIGURE 3 Experimental (left) and simulated (right) 31P NMR spectra as
a function of temperature for the complex DMPA:cardiotoxin at a lipid-
to-protein molar ratio of 40:1. The spectra used in the simulations are
represented by dotted lines.
simulations are given in Table 1 B. These results indicate
that at temperatures below that of the phase transition, only
two components are present, a typical lamellar phase spec-
trum with a width corresponding to that of pure DMPA and
a small isotropic peak. The relative intensity of the isotropic
peak increases from 11% at 25°C to 39% at 40°C, at the
expense of the lamellar phase component. However, at
temperatures above the phase transition temperature of the
pure lipid, a second spectrum with a spectral width of about
14 ppm is necessary to adequately simulate the experimen-
tal spectra, in a proportion ranging from 30% to 37% at
temperatures between 50 and 65°C. In these spectra, the
amount of isotropic peak is very small (less than 5%).
Assuming that the lamellar spectrum with a smaller CSA is
due to DMPA interacting with cardiotoxin, the number of
lipids in interaction with cardiotoxin varies from 5 at 25°C
to about 15 at temperatures above 45°C. This behavior is
very similar to that observed at a lipid-to-protein molar ratio
of 15:1.
Transverse relaxation times
The transverse relaxation time (T2), like other NMR observ-
ables, is sensitive to motions occurring on a specific time
scale. The T2 sensitivity reflects processes with correlation
times equal to the inverse chemical shift anisotropy, thus
offering a means of studying molecular dynamics in the
range of 10-7 to 10-2 s (Dufourc et al., 1992). Therefore,
the study of the transverse relaxation times allows the
investigation of a very useful range of correlation times.
The effect of temperature on the transverse relaxation
times obtained for DMPA in the absence and presence of
cardiotoxin is shown in Fig. 4. All transverse relaxation
times measured are characteristic of an organized phase
(Dufourc et al., 1992). The important changes in relaxation
times between lipid-to-protein molar ratios of 1:0 and 5:1
suggest significant differences in the dynamics of the iso-
tropic and anisotropic phases. These differences become
more important at temperatures close to the phase transition
temperature. For the pure lipid system, all curves have been
fitted with a monoexponential decay. The relaxation time
starts to increase at 40°C and reaches a maximum at 45°C.
At 50°C, the T2 is back to its value measured before the
phase transition. Such an increase of T2 at the gel to liquid-
crystalline phase transition has also been observed for other
phospholipids (Dufourc et al., 1992).
For the complex at a lipid-to-protein molar ratio of 40:1,
the T2 obtained at low temperatures were fitted with a
monoexponetial function and are very similar to those ob-
tained for pure DMPA. However, after the phase transition
temperature of the pure lipid, the T2 decay was best fitted
with two exponentials. The shortest T2, presented in Fig. 4,
is longer than that observed for pure DMPA. In this system,
a second component is also present with a T2 greater than 10
ms. The exact value of this T2 could not be calculated
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FIGURE 4 31P NMR transverse relaxation times (T2) as a function of
temperature for different DMPA-cardiotoxin molar ratios. 0, 1:0; A, 40:1;
*, 15:1; *, 5:1;. The T2 curves were fitted either with a mono- or
biexponential decay. The shortest T2 obtained from the fits are shown on
this figure.
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TABLE I Parameters used in the spectral simulations
Lamellar phase 1 Lamellar phase 2 Isotropic phase
T Proportiont CSA' Proportion CSA Proportion WHHI Interaction
(OC) (%) (ppm) (%) (ppm) (%) (ppm) ratio*
A. DMPA-to-cardiotoxin molar ratio of 15:1
25 54 39 46 11 7
30 52 39 - 48 11 7
35 44 39 - - 56 8 8
40 31 39 - 69 8 10
45 27 39 - 73 6 11
50 16 38 84 6 13
55 100 6 15
65 100 6 15
B. DMPA-to-cardiotoxin molar ratio of 40:1
25 89 44 11 8 5
30 83 44 17 8 7
35 79 46 21 6 9
40 61 42 39 5 16
45 64 38 5 14 31 4 15
50 68 33 30 14 3 7 13
55 66 32 32 14 2 7 14
60 62 32 35 14 3 7 15
65 59 31 37 14 4 7 16
Calculated number of lipids in interaction with cardiotoxin.
t The estimated error on the proportion of each phase is 3%.
§ Chemical shift anisotropy.
Width of half-height.
precisely because of the very small intensities obtained at
longer T values in the T2 experiments.
For the complex with a lipid-to-protein molar ratio of
15:1, every T2 curve was fitted with a monoexponential
decay. At this lipid-to-protein molar ratio, the temperature
dependence of T2 is characterized by two plateau regions,
below and above the phase transition temperature of the
pure lipid. At low temperatures, the T2 are similar to those
observed for pure DMPA, whereas at high temperatures,
higher T2 values are obtained.
For the complex with a lipid-to-protein molar ratio of 5:1,
the T2 curves were fitted with a monoexponential decay at
temperatures below that of the phase transition of the pure
lipid. The T2 increases gradually between 25°C and 50°C,
where a plateau is reached, as was observed for the 15:1
molar ratio. At higher temperatures, the T2 curves were best
fitted with a biexponential decay, and the shortest T2 shown
on Fig. 4 are very similar to those obtained at the 15:1 molar
ratio. A second component with a T2 greater than 10 ms was
detected at high temperatures for the lipid-to-protein molar
ratio of 5:1.
Hydrophobic extraction
Several structures can give rise to an isotropic peak in 31p
NMR spectra. To test the possible formation of a hydro-
phobic phase, we have performed a hydrophobic extraction
based on the method of Batenburg et al. (1985). By this
method, an aqueous solution of cardiotoxin and DMPA is
mixed with chloroform. Usually, when cardiotoxin is mixed
with DMPA in water at a lipid-to-protein molar ratio of 5:1,
a precipitate is formed. However, in the presence of chlo-
roform, the solution became clear, indicating that the com-
plex is soluble in this solvent. Analysis by spectrophotom-
etry showed that 80% of the cardiotoxin is transferred from
the aqueous solution to the hydrophobic phase. Because
Batenburg et al. (1985) have shown that no detectable
amount of cardiotoxin is transferred when an aqueous so-
lution of pure cardiotoxin is mixed with an organic phase,
the hydrophobic extraction of cardiotoxin in the presence of
lipids indicates that the protein is present within a hydro-
phobic complex.
DISCUSSION
Disappearance of the bilayer structure
The results presented above indicate that cardiotoxin inter-
acts with DMPA bilayers and that at all molar ratios studied
there is the apparition of a new isotropic phase. The isotro-
pic peak can be associated with phospholipids interacting
with cardiotoxin and the lamellar lineshape with pure
DMPA bilayers. The disappearance of the lamellar line-
shape suggests the formation of small isotropic structures
that give rise to a complete averaging of the chemical shift
anisotropy in the 31p spectra.
Isotropic spectra in solid-state 31P NMR spectroscopy
can be due to the formation of small vesicles, micelles,
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cubic phases, or inverted micelles. The formation of small
vesicles or hydrophilic micelles is very unlikely, based on
the results of the hydrophobic extraction, which suggested
the formation of a hydrophobic (inverted) structure. This
structure has to be small to explain the isotropic band in the
31P NMR spectra and therefore could not be an inverted
hexagonal (HI,) phase. The most likely candidate is there-
fore the formation of a hydrophobic complex similar to an
inverted micelle, as it has also been suggested for com-
plexes of cardiotoxin with cardiolipin (Batenburg et al.,
1985).
Mixed inverted micelles of DMPA and cardiotoxin
The results obtained strongly suggest the formation of in-
verted micelles that are most likely formed by DMPA
molecules interacting directly with cardiotoxin. This inter-
action is electrostatic and most likely localized at the
charges of the protein. The interaction should therefore
result in a neutralization of the charges of cardiotoxin and of
the phospholipids interacting with the protein. A hydropho-
bic complex is therefore formed. Because there are few lipid
molecules (5 to 15) associated with each cardiotoxin mol-
ecule, the hydrophobic complex has some similarities with
an inverted micelle but has an irregular shape.
Inverted micellar structures have been observed in some
lipid systems as intermediate phases in cell fusion or phase
transition (Siegel, 1984, 1986a,b). They are often present
between bilayers (i.e., in a hydrophobic region; Cullis and
Hope, 1978), and they are mostly observed in systems that
show a tendency to form inverted hexagonal phases. In-
verted micelles were originally observed by freeze-fracture
microscopy and NMR spectroscopy (de Kruijff et al., 1979;
for a review see Verkleij, 1984). Recently, the possibility of
stacked inverted micelles of membrane lipids in a cubic
phase was suggested (Lindblom and Rilfors, 1989) and
confirmed by several groups for systems such as phosphati-
dylcholine-diacylglycerol-water (Seddon, 1990b; Lindblom
and Oradd, 1994; Oradd et al., 1995).
Our results show that at room temperature, the formation
of the isotropic phase is complete at a lipid-to-protein molar
ratio of 5:1 and incomplete for ratios of 15:1 and 40:1. This
suggests that there are about 5 to 10 phospholipids and one
cardiotoxin by inverted micelle at that temperature. On the
other hand, the spectra obtained at higher temperatures for
the molar ratios of 15:1 and 40:1 indicate that there is an
increase in the number of phospholipids interacting with
cardiotoxin with increasing temperature, with up to 15
phospholipids per cardiotoxin above the phase transition of
the pure lipid system.
Because the isotropic structure is formed at every
phospholipid-to-cardiotoxin molar ratio, it appears to be
more stable than the DMPA bilayers. The hydrophobic
complex could be formed by membrane fusion, according
to the model of Cullis and Hope (1978), so that the
cardiotoxin would not have to penetrate into the lipid
bilayers. It is interesting to note that the peaks observed
at 65°C for the lipid-to-protein molar ratios of 5:1 and
15:1 are very similar to the isotropic peak characteristic
of a cubic phase made of inverted micelles (Seddon,
1990b; Lindblom and Oriidd, 1994; Oradd et al., 1995).
Therefore, the disappearance of the bilayer structure most
likely results in hydrophobic complexes stabilized by
hydrophobic interactions.
The T2 values obtained for the lipid-to-protein molar
ratios of 15:1 and 5:1 are characteristic of an organized
phase despite the observation of isotropic spectra. This is
understandable if the small structures formed upon the
interaction of DMPA with cardiotoxin are motionally re-
stricted because of hydrophobic interactions. For the lipid-
to-protein molar ratio of 15:1, the T2 are similar to those
observed for pure DMPA at low temperatures, whereas at
high temperatures the higher T2 values reflect the greater
motions of the lipids in the hydrophobic complex. For the
complex with a lipid-to-protein molar ratio of 5:1, the
shortest T2 shown on Fig. 4 are very similar to those
obtained at the 15:1 molar ratio. This suggests that the
motions dominating the T2 relaxation in these systems are
the internal motions of the lipid molecules. The second
component with a T2 greater than 10 ms detected at high
temperatures can most likely be attributed to the faster
rotation of the hydrophobic complex.
Formation of a second anisotropic phase
For the lipid-to-protein molar ratio of 40:1, the coexistence
of a lamellar lineshape and of an isotropic peak at low
temperatures suggests that the hydrophobic complex is out-
side the bilayers. At high temperatures, the spectra indicate
the coexistence of two anisotropic phases, a nonperturbed
lamellar phase and a perturbed phase with a chemical shift
anisotropy of 14 ppm. The formation of a second lamellar
phase at high temperatures suggests that the hydrophobic
complex is incorporated into the lipid lamellar phase. The
smaller CSA obtained for the second lamellar phase can be
explained by the neutralization of the charges of the DMPA
molecules in the complex, resulting from the electrostatic
interaction with cardiotoxin. In a recent article (Pott et al.,
1995) it has been demonstrated that the chemical shift
anisotropy of uncharged DMPA in the liquid-crystalline
phase is 14 ppm. This corresponds exactly to the chemical
shift anisotropy observed above the phase transition tem-
perature for the DMPA:cardiotoxin complex at a lipid-to-
protein molar ratio of 40:1. On the other hand, the T2 decay
was best fitted with two exponentials in this system at high
temperatures. The shortest T2 (presented in Fig. 4) is longer
than that observed for pure DMPA, which suggests that the
lamellar phase lipids are perturbed, most likely because of
the incorporation of the hydrophobic complex inside the
bilayer.
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Literature results explained by an inverted
micelle structure
It is interesting to note that the inverted micelle model can
satisfactorily explain several observations reported in the
literature. Hence, the hydrophobicity of the complex could
explain the precipitate observed by several groups (Vincent
et al., 1976; Faucon et al., 1979). In addition, the synergetic
effect between cardiotoxin and phospholipase A2 (Louw
and Visser, 1978; Gulik-Krzywicki et al., 1981; Rivas et al.,
1981; Harvey et al., 1983) could also be explained by the
formation of an inverted structure in which the acyl chains
are more accessible.
The abolition of the thermotropic phase transition of
DMPA in the presence of cardiotoxin has been observed by
DSC, fluorescence polarization, and infrared spectroscopy
(Faucon et al., 1981, 1983; D6sormeaux et al., 1992). In
addition, it has been determined by attenuated total reflec-
tion FTIR spectroscopy (Desormeaux et al., 1992) that both
the lipid and cardiotoxin in the complex are poorly ordered.
In addition, the FTIR results indicate that at a lipid-to-
protein molar ratio of 5:1, the number of gauche conformers
in the DMPA acyl chains is the same in both the gel and the
liquid-crystalline phases. This large increase of the number
of gauche conformers and the fact that the complex is
poorly ordered are consistent with a micellar structure.
Comparison with other models
Three other models have been suggested in the literature to
explain the interactions between cardiotoxin and negatively
charged phospholipids. In the model of Lauterwein and
Wiithrich (1978), cardiotoxin spans the membrane com-
pletely to interact with the phosphate group on the two sides
of the bilayer. On the other hand, Dufourcq et al. (1982)
have suggested that the initial electrostatic interactions of
the basic residues of cardiotoxins with negatively charged
phospholipids is followed by the incorporation of at least
the N-terminal hydrophobic loop into the bilayers. Finally,
Batenburg et al. (1985) have suggested that in the case of
the interaction of cardiotoxin with cardiolipin (a doubly
charged phospholipid), the protein resides with its polar part
in the interior of two inverted micelles and its hydrophobic
(3-pleated sheet in the acyl chain region.
The two models involving lipid bilayers cannot satisfac-
torily explain the isotropic peak obtained by 31p NMR
spectroscopy or the solubility of the complex in a hydro-
phobic solvent observed in the present study at low lipid-
to-protein molar ratios. In this case, the hydrophobic com-
plex is most likely similar to the model proposed by
Batenburg et al. (1985) for the interaction between cardio-
lipin and cardiotoxin. However, it is important to note that
cardiolipin is known to form inverted structures (de Kruijff
and Cullis, 1980) in conditions where DMPA does not
(Laroche et al., 1988, 1991). For the lipid-to-protein molar
ratio of 40:1, the formation of a second lamellar phase at
high temperatures suggests that the hydrophobic complex is
incorporated into the lipid lamellar phase, in a model similar
to that suggested by Lauterwein and Wuthrich (1978).
In conclusion, the strong electrostatic interactions be-
tween cardiotoxin Ha extracted from Naja mossambica
mossambica and dimyristoylphosphatidic acid results in the
disappearance of the bilayer structure and the formation of
an isotropic phase at small lipid-to-protein molar ratios,
which gives rise to an isotropic peak in the solid-state 31P
NMR spectra. At high lipid-to-protein molar ratios, our
results suggest that the hydrophobic complex is incorpo-
rated into the lipid bilayer in the liquid-crystalline phase.
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